Israel Englander Eye Point Pharmaceuticals, Inc. Transaction History
Millennium Management LLC
- $207 Billion
- Q2 2024
A detailed history of Israel Englander (Millennium Management LLC) transactions in Eye Point Pharmaceuticals, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 580,716 shares of EYPT stock, worth $7.02 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
580,716
Previous 2,046,438
71.62%
Holding current value
$7.02 Million
Previous $42.3 Million
88.06%
% of portfolio
0.0%
Previous 0.02%
Shares
7 transactions
Others Institutions Holding EYPT
# of Institutions
158Shares Held
57.4MCall Options Held
224KPut Options Held
1.41M-
Cormorant Asset Management, LP Boston, MA8.33MShares$101 Million5.57% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.18MShares$62.5 Million1.88% of portfolio
-
Black Rock Inc. New York, NY3.76MShares$45.5 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA3.65MShares$44.1 Million0.01% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.59MShares$43.4 Million0.06% of portfolio
About EyePoint Pharmaceuticals, Inc.
- Ticker EYPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 34,072,200
- Market Cap $412M
- Description
- EyePoint Pharmaceuticals, Inc., a pharmaceutical company, develops and commercializes ophthalmic products for the treatment of eye diseases in the United States, China, and the United Kingdom. The company provides ILUVIEN, an injectable sustained-release micro-insert for treatment of diabetic macular edema; YUTIQ, a fluocinolone acetonide intrav...